The Combination of GnRh Analogue and Aromatase Inhibitor in Receptor Positive Premenopausal Women With Advanced Breast Cancer

• Conditions: Advanced Breast Cancer

• Registration Number: NCT01311037
• Lead Sponsor: King Faisal Specialist Hospital & Research Center

Brief Summary

The Combination of GnRh Analogue and Aromatase Inhibitor in Receptor Positive Premenopausal Women with Advanced Breast Cancer A Prospective Trial.

Detailed Description

The Combination of GnRh Analogue and Aromatase Inhibitor in Receptor Positive Premenopausal Women with Advanced Breast Cancer A Prospective Trial.

Study Timeline

• Study Start: 2009-01
• Study First Submitted: 2011-03-06
• Study First Submitted QC: 2011-03-08
• Study First Posted: 2011-03-09
• Status Verified: 2011-12
• Last Update Submitted: 2011-12-11
• Last Update Posted: 2011-12-13

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: Female
• Target Recruitment: 2

Inclusion Criteria

• Receptor Positive Premenopausal Women with Advanced Breast Cancer.

Exclusion Criteria

• Any woman other than diagnosis of Receptor Positive Premenopausal with Advanced Breast Cancer.

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Trial Locations

Locations (1)

Kfsh & Rc; 🇸🇦 Riyadh, Saudi Arabia